Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BA058 Transdermal vs Placebo in Postmenopausal Osteoporosis (Phase 2)
2012-001921-29Phase 2Completed
- Sponsor
- Radius Health Inc
- Start
- Jun 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in osteoporosis comparing BA058 Transdermal with Placebo (2 arms). Primary endpoint: Change in lumbar spine bone mineral density. Started Jun 2012; status: completed.
02
Drugs
abaloparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on 2012-001921-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001921-29.